Langfang Kairui Tamishi Medical Supplies Co., Ltd. – Trademark Portfolio
Entity Type: 99
Langfang Kairui Tamishi Medical Supplies Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include ARCHYSAMOS. The owner is based in Langfang,Hebei.
Huaxia Happiness City, Guangyang District
Room 203, Unit 1, Building 9, Runyuan
Langfang,Hebei 065000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Langfang Kairui Tamishi Medical Supplies Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Langfang Kairui Tamishi Medical Supplies Co., Ltd. have?
Langfang Kairui Tamishi Medical Supplies Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Langfang Kairui Tamishi Medical Supplies Co., Ltd. file in?
Langfang Kairui Tamishi Medical Supplies Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 3 (Cosmetics & Cleaning). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are Langfang Kairui Tamishi Medical Supplies Co., Ltd.'s most well-known trademarks?
Langfang Kairui Tamishi Medical Supplies Co., Ltd.'s registered trademark portfolio includes well-known marks such as ARCHYSAMOS. These are among 1 currently registered trademark in the portfolio.
What is Langfang Kairui Tamishi Medical Supplies Co., Ltd.'s trademark registration success rate?
Langfang Kairui Tamishi Medical Supplies Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.